JP2002520356A - 細胞毒性剤による腫瘍の処理への使用が意図された、フラボノイドに基づく治療組成物 - Google Patents

細胞毒性剤による腫瘍の処理への使用が意図された、フラボノイドに基づく治療組成物

Info

Publication number
JP2002520356A
JP2002520356A JP2000559841A JP2000559841A JP2002520356A JP 2002520356 A JP2002520356 A JP 2002520356A JP 2000559841 A JP2000559841 A JP 2000559841A JP 2000559841 A JP2000559841 A JP 2000559841A JP 2002520356 A JP2002520356 A JP 2002520356A
Authority
JP
Japan
Prior art keywords
treatment
protocol
tumor
flavonoid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000559841A
Other languages
English (en)
Japanese (ja)
Inventor
ダッロ，フランシス
キス，ロベール
フリードマン，アルマン
Original Assignee
ラボラトワール エル．ラフォン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラボラトワール エル．ラフォン filed Critical ラボラトワール エル．ラフォン
Publication of JP2002520356A publication Critical patent/JP2002520356A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
JP2000559841A 1998-07-15 1999-07-13 細胞毒性剤による腫瘍の処理への使用が意図された、フラボノイドに基づく治療組成物 Pending JP2002520356A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/09058 1998-07-15
FR9809058A FR2781153B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
PCT/FR1999/001714 WO2000003706A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base de flavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Publications (1)

Publication Number Publication Date
JP2002520356A true JP2002520356A (ja) 2002-07-09

Family

ID=9528648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000559841A Pending JP2002520356A (ja) 1998-07-15 1999-07-13 細胞毒性剤による腫瘍の処理への使用が意図された、フラボノイドに基づく治療組成物

Country Status (12)

Country Link
EP (1) EP1096930A1 (zh)
JP (1) JP2002520356A (zh)
KR (1) KR20020003349A (zh)
CN (1) CN1139384C (zh)
AU (1) AU4789099A (zh)
BR (1) BR9912816A (zh)
CA (1) CA2337179A1 (zh)
EA (1) EA200100140A1 (zh)
FR (1) FR2781153B1 (zh)
IL (1) IL140588A0 (zh)
WO (1) WO2000003706A1 (zh)
ZA (1) ZA200100239B (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011520867A (ja) * 2008-05-16 2011-07-21 ベリトロン・リミテッド 植物抽出物およびその治療上の使用
JP2018002645A (ja) * 2016-06-30 2018-01-11 国立大学法人広島大学 抗癌剤作用増強物質およびそれを備えた抗癌剤キット

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002069949A2 (en) * 2001-03-06 2002-09-12 Prendergast Patrick T Combination therapy for reduction of toxycity of chemotherapeutic agents
EP1808172A3 (en) * 2002-03-06 2010-05-26 Activephyto Technologies Limited Botanical extract compositions and methods of use
DE60313754T2 (de) * 2002-03-06 2008-01-24 The Medical Research and Education Trust, San Diego Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
CN1679539A (zh) * 2005-01-20 2005-10-12 吴一心 抗肿瘤的协同药物组合物
EP1856083A4 (en) * 2005-03-11 2009-05-27 Univ Michigan CHROMEN-4-ONE INHIBITORS OF ANTI-APOPTOTIC ELEMENTS OF THE BCL-2 FAMILY AND USES THEREOF
US9808439B2 (en) * 2015-07-29 2017-11-07 Macau University Of Science And Technology Use of tangeretin in cancer treatment
US9808477B2 (en) * 2015-07-29 2017-11-07 Macau University Of Science And Technology Use of nobiletin in cancer treatment
CN106562954A (zh) * 2016-11-11 2017-04-19 黄冈师范学院 (去甲基)多甲氧基黄酮联合紫杉醇类药物在制备治疗非小细胞肺癌的药物上的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
JPS5959627A (ja) * 1982-09-27 1984-04-05 Tatsuo Miyoshi 制癌剤
JPS60199817A (ja) * 1984-03-23 1985-10-09 Rikagaku Kenkyusho 制癌剤
JPS632925A (ja) * 1986-06-23 1988-01-07 Nippon Kayaku Co Ltd Ｃキナ−ゼ阻害剤および抗腫瘍剤
FR2633182B1 (fr) * 1988-06-23 1993-07-23 Beljanski Mirko Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
JPH04103529A (ja) * 1990-08-24 1992-04-06 Tatsuo Miyoshi 制癌剤
JPH04103532A (ja) * 1990-08-24 1992-04-06 Tatsuo Miyoshi 制癌剤
JP2514500B2 (ja) * 1991-09-14 1996-07-10 呉羽化学工業株式会社 多剤耐性抑制剤及び発現阻害剤
AU4272293A (en) * 1992-05-11 1993-12-13 Tsumura & Co. Apoptosis inducer
WO1996031206A2 (en) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
DE29719198U1 (de) * 1997-10-29 1998-04-23 Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, 14558 Bergholz-Rehbrücke Flavono/Flavonoid-Zubereitung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011520867A (ja) * 2008-05-16 2011-07-21 ベリトロン・リミテッド 植物抽出物およびその治療上の使用
JP2018002645A (ja) * 2016-06-30 2018-01-11 国立大学法人広島大学 抗癌剤作用増強物質およびそれを備えた抗癌剤キット

Also Published As

Publication number Publication date
EA200100140A1 (ru) 2001-06-25
CN1139384C (zh) 2004-02-25
FR2781153A1 (fr) 2000-01-21
EP1096930A1 (fr) 2001-05-09
KR20020003349A (ko) 2002-01-12
BR9912816A (pt) 2001-05-08
CN1313765A (zh) 2001-09-19
IL140588A0 (en) 2002-02-10
WO2000003706A1 (fr) 2000-01-27
ZA200100239B (en) 2002-01-09
FR2781153B1 (fr) 2001-08-03
AU4789099A (en) 2000-02-07
CA2337179A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
ES2282400T3 (es) Composiciones antitumorales que contienen derivados de taxano.
EP1097138B1 (fr) Compositions pharmaceutiques comprenant des 2-quinolones
TWI222863B (en) Synergistic pharmaceutical compositions comprising anthracycline derivatives and anticancer agents
AU2002311985B9 (en) Methods for inhibiting angiogenesis
US20090312373A1 (en) Methods for the treatment of cancer using piperlongumine and piperlongumine analogs
JP2003528920A (ja) 血管損傷性活性を有する併用療法
JP2002520356A (ja) 細胞毒性剤による腫瘍の処理への使用が意図された、フラボノイドに基づく治療組成物
CN109715157A (zh) 用于治疗癌症的组合
AU2018352382B2 (en) Compounds and methods for treating cancer
AU761417B2 (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
TWI598097B (zh) 包含卡巴利他索（ｃａｂａｚｉｔａｘｅｌ）及順鉑（ｃｉｓｐｌａｔｉｎ）之抗腫瘤組合
WO2016175252A1 (ja) ピラジンカルボキサミド化合物を有効成分とする医薬組成物
TWI454280B (zh) Pharmaceutical composition or combination
EA016873B1 (ru) Применение для лечения лейкемии
JP2007523215A (ja) 癌治療のためのβ−ラパコンおよびＳ期薬組み合わせ
MXPA01000389A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
MXPA01000387A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
CN102485735A (zh) 6-果糖氨-4-芳胺基喹唑啉衍生物及其用途
WO2013091052A1 (pt) Composto molecular que compreende uma molécula de acridina ligada quimicamente a um grupamento carboxílico útil para a destruição seletiva de células de tumores sólidos
BR112020024037A2 (pt) compostos orgânicos
JP2006504722A (ja) ジェムシタビンおよびｚｄ６１２６での組合せ療法